SUNDAY, Sept. 16, 2018 — There’s disappointing news for seniors: A new trial shows that taking daily low-dose aspirin doesn’t
Continue reading »Home ยป
Daily low-dose aspirin found to have no effect on healthy life span in older people
In a large clinical trial to determine the risks and benefits of daily low-dose aspirin in healthy older adults without
Continue reading »Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Combination Approved for Previously Treated MSI-H/dMMR Metastatic Colorectal Cancer
PRINCETON, N.J.– July 11, 2018 (BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy
Continue reading »